Related Experiment Video
Updated: Sep 26, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes
Milagros G Huerta1, Jerry L Nadler
1Division of Endocrinology and Metabolism, University of Virginia, P.O. Box 801405, Fontaine Research Park, 450 Ray C. Hunt Drive, Fontaine Medical Research Building, 1st Floor Room #1220, Charlottesville, VA 22908-1405, USA.
Abstract:
Experimental and epidemiologic studies support the role of inflammation in the development of type 2 diabetes and atherosclerosis. Serum levels of inflammatory markers, in particular highly sensitive C-reactive protein, have been found to be strong predictors of increased risk for type 2 diabetes and cardiovascular disease independent of traditional risk factors. A beneficial effect of thiazolidinediones, angiotensin-converting enzyme inhibitors, and statins in the prevention of type 2 diabetes and cardiovascular events has recently been reported, and potential anti-inflammatory mechanisms of action for these compounds have been described. Prospective, randomized clinical trials are currently underway to confirm these initial findings and define indications for treatment of patients at risk.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Coronary Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Coronary Artery Disease II: Pathophysiology